NCT00288470已完成不适用
A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.
Genzyme, a Sanofi Company0 个研究点开始时间: 2002年6月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 主要终点
- Non-inferiority as compared to standard of care as assigned by blinded reviewer.
研究概览
简要总结
A clinical study to investigate the safety and efficacy of Hylaform and Hylaform Plus for correction of facial wrinkles.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 30 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •bilateral nasolabial folds with severity score 3 or 4 on the 6-point grading scale
排除标准
- •pregnant/lactating women
- •patients who previously received permanent facial implants or using ovet-the-counter products
结局指标
主要结局
Non-inferiority as compared to standard of care as assigned by blinded reviewer.
次要结局
未报告次要终点
研究者
相似试验
终止
3 期
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2Urinary IncontinenceOveractive BladderNCT02660359Ipsen258
终止
3 期
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1Urinary IncontinenceOveractive BladderNCT02660138Ipsen227
已完成
1 期
Safety, Tolerability and Immunogenicity of Two Different Formulations of an Influenza A Vaccine (FP-01.1)Influenza ANCT01677676Immune Targeting Systems Ltd48
撤回
不适用
Safety and Efficacy Study of Lidocaine Mixed Hyaluronate on Nasolabial Folds CorrectionNasolabial Folds CorrectionPainNCT02006173SciVision Biotech Inc.
已完成
2 期
A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and ChildrenDengue Hemorrhagic FeverDengue Shock SyndromeDengue FeverNCT00468858U.S. Army Medical Research and Development Command636